Related references
Note: Only part of the references are listed.OPTN/SRTR 2021 Annual Data Report: Liver
Allison J. Kwong et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2023)
Utilization of hepatitis B virus surface antigen positive grafts in liver transplantation: A matched study based on a national registry cohort
Songfeng Yu et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2022)
Prospective Multicenter Study of Early Antiviral Therapy in Liver and Kidney Transplant Recipients of HCV-Viremic Donors
Norah A. Terrault et al.
HEPATOLOGY (2021)
Liver Transplantation Using Hepatitis C Virus-Viremic Donors Into Hepatitis C Virus-Aviremic Recipients as Standard of Care
Humberto Bohorquez et al.
LIVER TRANSPLANTATION (2021)
The current status of virus-positive liver transplantation
Aaron M. Delman et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2021)
Hepatitis C-positive liver transplantation: outcomes and current practice
Christopher J. Danford et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2021)
Outcomes following liver transplantation from HCV-seropositive donors to HCV-seronegative recipients
Bashar Aqel et al.
JOURNAL OF HEPATOLOGY (2021)
Expanding the Donor Pool: First Use of Hepatitis B Virus Nat Positive Solid Organ Allografts Into Seronegative Recipients
Aaron M. Delman et al.
ANNALS OF SURGERY (2021)
Liver and Kidney Recipient Selection of Hepatitis C Virus Viremic Donors: Meeting Consensus Report From the 2019 Controversies in Transplantation
James R. Burton et al.
TRANSPLANTATION (2020)
Immediate administration of antiviral therapy after transplantation of hepatitis C-infected livers into uninfected recipients: Implications for therapeutic planning
Emily Bethea et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2020)
Risk of disease transmission in an expanded donor population: the potential of hepatitis B virus donors
Kali Zhou et al.
CURRENT OPINION IN ORGAN TRANSPLANTATION (2020)
Increasing Trends in Transplantation of HCV-Positive Livers Into Uninfected Recipients
George Cholankeril et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Increasing Utilization and Excellent Initial Outcomes Following Liver Transplant of Hepatitis C Virus (HCV)-Viremic Donors Into HCV-Negative Recipients: Outcomes Following Liver Transplant of HCV-Viremic Donors
Thomas G. Cotter et al.
HEPATOLOGY (2019)
Liver transplantation using hepatitis B core positive grafts with antiviral monotherapy prophylaxis
Tiffany Cho-Lam Wong et al.
JOURNAL OF HEPATOLOGY (2019)
Improved Graft Survival After Liver Transplantation for Recipients With Hepatitis C Virus in the Direct-Acting Antiviral Era
Thomas G. Cotter et al.
LIVER TRANSPLANTATION (2019)
Hepatitis C-positive donor liver transplantation for hepatitis C seronegative recipients
Peng-sheng Ting et al.
TRANSPLANT INFECTIOUS DISEASE (2019)
Liver transplantation for hepatitis C virus (HCV) non-viremic recipients with HCV viremic donors
Allison J. Kwong et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2019)
Use of Hepatitis C Virus Antibody-Positive Donor Livers in Hepatitis C Nonviremic Liver Transplant Recipients
Keith Luckett et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2019)
Expanding the donor pool: Hepatitis C, hepatitis B and human immunodeficiency virus-positive donors in liver transplantation
James F. Crismale et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
Efficacy of Glecaprevir/Pibrentasvir for 8 or 12 Weeks in Patients With Hepatitis C Virus Genotype 2, 4, 5, or 6 Infection Without Cirrhosis
Tarik Asselah et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Baseline Factors Associated With Improvements in Decompensated Cirrhosis After Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection
Omar El-Sherif et al.
GASTROENTEROLOGY (2018)
Hepatitis C transmission from seropositive, nonviremic donors to non-hepatitis C liver transplant recipients
Khurram Bari et al.
HEPATOLOGY (2018)
Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection
Nancy Reau et al.
HEPATOLOGY (2018)
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
Norah A. Terrault et al.
HEPATOLOGY (2018)
Long-term outcome and recurrence of hepatitis B virus following liver transplantation from hepatitis B surface antigen-positive donors in a Chinese population
Lai Wei et al.
JOURNAL OF VIRAL HEPATITIS (2018)
What are the outcomes of declining a public health service increased risk liver donor for patients on the liver transplant waiting list?
Kristopher P. Croome et al.
LIVER TRANSPLANTATION (2018)
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection
S. Zeuzem et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Changes in Utilization and Discard of Hepatitis C-Infected Donor Livers in the Recent Era
M. G. Bowring et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2017)
Impact of viral eradication with sofosbuvir-based therapy on the outcome of post-transplant hepatitis C with severe fibrosis
Silvia Martini et al.
LIVER INTERNATIONAL (2017)
Glecaprevir and Pibrentasvir for 12 Weeks for Hepatitis C Virus Genotype 1 Infection and Prior Direct-Acting Antiviral Treatment
Fred Poordad et al.
HEPATOLOGY (2017)
Glecaprevir and pibrentasvir yield high response rates in patients with HCV genotype 1-6 without cirrhosis
Paul Y. Kwo et al.
JOURNAL OF HEPATOLOGY (2017)
Solid Organ Transplantation From Hepatitis B Virus-Positive Donors: Consensus Guidelines for Recipient Management
S. Huprikar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
G. R. Foster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection
J. J. Feld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Use of Hepatitis B Surface Antigen-Positive Grafts in Liver Transplantation: A Matched Analysis of the US National Database
Zhiwei Li et al.
LIVER TRANSPLANTATION (2014)
Allografts Positive for Hepatitis B Surface Antigen in Liver Transplant for Disease Related to Hepatitis B Virus
Weiqiang Ju et al.
EXPERIMENTAL AND CLINICAL TRANSPLANTATION (2013)
Liver Transplantation From Hepatitis B Surface Antigen-Positive Donors
R. F. Saidi et al.
TRANSPLANTATION PROCEEDINGS (2013)
Risk of de novo hepatitis in liver recipients from hepatitis-B core antibody-positive grafts - a systematic analysis
Catherine L. Skagen et al.
CLINICAL TRANSPLANTATION (2011)
Managing patients with hepatitis-B-related or hepatitis-C-related decompensated cirrhosis
Scott A. Fink et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Long-Term Follow-Up and Outcome of Liver Transplantation From Anti-Hepatitis C Virus-Positive Donors: A European Multicentric Case-Control Study
Roberto Ballarin et al.
TRANSPLANTATION (2011)
Liver grafts from anti-hepatitis B core positive donors: A systematic review
Evangelos Cholongitas et al.
JOURNAL OF HEPATOLOGY (2010)
Hepatitis C positive grafts may be used in orthotopic liver transplantation: A matched analysis
S Saab et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2003)
Transplantation of hepatitis C-positive livers in hepatitis C-positive patients is equivalent to transplanting hepatitis C-negative livers
CE Marroquin et al.
LIVER TRANSPLANTATION (2001)
Share Paper
